Acta Dermato-venereologica
Overview
Acta dermato-venereologica is a peer-reviewed medical journal that focuses on dermatology and venereology. It publishes original research articles, clinical studies, and reviews related to skin diseases, sexually transmitted infections, and related fields. The journal aims to provide valuable insights into the diagnosis, treatment, and prevention of dermatological and venereal conditions, making it a valuable resource for dermatologists, venereologists, and other healthcare professionals.
Details
Details
Abbr.
Acta Derm Venereol
Start
1920
End
Continuing
Frequency
Annual, 2022-
p-ISSN
0001-5555
e-ISSN
1651-2057
Country
Sweden
Languages
English
French
German
French
German
Specialty
Dermatology
Metrics
Metrics
h-index / Ranks: 3275
97
SJR / Ranks: 3728
1015
CiteScore / Ranks: 5670
4.60
JIF / Ranks: 2654
3.6
Recent Articles
1.
Hedebo S, Pedersen M, Lindahl L, Drjlevic-Nielsen A, Johansen C, DAmore F, et al.
Acta Derm Venereol
. 2025 Mar;
105:adv40952.
PMID: 40079767
Cutaneous T-cell lymphomas are a heterogeneous group of non-Hodgkin lymphomas. Early stages are often controlled with skin-directed therapy, such as topical corticosteroids, topical chlormethine gel, or UV therapy, whereas advanced...
2.
Iinuma K, Fujii K, Usui S, Itani Y, Otsuka A
Acta Derm Venereol
. 2025 Mar;
105:adv43111.
PMID: 40077981
No abstract available.
3.
Jankowska K, Kokoszka J, Szepietowski J
Acta Derm Venereol
. 2025 Mar;
105:adv43059.
PMID: 40077980
No abstract available.
4.
Muller S, Zeidler C, Mess C, Kahnert S, Lowe B, Weigel A, et al.
Acta Derm Venereol
. 2025 Mar;
105:adv42773.
PMID: 40077979
Chronic pruritus (≥ 6 weeks) is a frequent symptom in atopic diseases, with phenotypes ranging from non-lesional skin to inflammatory diseases like atopic dermatitis. Data on patients' needs and treatment...
5.
Biasotti V, Iacono D, Pilotto C, Bigucci B, Martini G
Acta Derm Venereol
. 2025 Mar;
105:adv42482.
PMID: 40077978
No abstract available.
6.
Calabrese L, Cinotti E, DOnghia M, Cartocci A, Rubegni P, Maccari F, et al.
Acta Derm Venereol
. 2025 Mar;
105:adv42275.
PMID: 40077977
Tralokinumab is a monoclonal antibody selectively targeting IL-13, approved for moderate-to-severe atopic dermatitis (AD), for which real-world data are scarce. This prospective, observational, multicentric study aimed to assess the long-term...
7.
Miyahara H, Honda R, Ito S, Ishii N, Nomura T
Acta Derm Venereol
. 2025 Mar;
105:adv41369.
PMID: 40077976
No abstract available.
8.
Jensen M, Loft N, Zachariae C, Skov L
Acta Derm Venereol
. 2025 Mar;
105:adv42987.
PMID: 40059467
No abstract available.
9.
Chen A, Liu L, Yang H, Luo X, Xiang J
Acta Derm Venereol
. 2025 Mar;
105:adv42776.
PMID: 40059466
Pemphigus is a rare and life-threatening autoimmune disease that is easily ignored in children. This study aimed to attract attention to pemphigus in the paediatric population for better understanding and...
10.
Schlosser A, Nijman L, Schappin R, Nijsten T, Hijnen D
Acta Derm Venereol
. 2025 Mar;
105:adv41504.
PMID: 40059465
In recent years, several new systemic agents (biologics and Janus kinase inhibitors [JAKi]) have been registered for the treatment of moderate-to-severe atopic dermatitis (AD). However, comparisons of real-world drug survival...